Amrubicin improved response rate and progression-free survival vs. topotecan in Phase III trial
2011-07-10
(Press-News.org) Lung cancer patients given amrubicin (Calsed) as a second-line therapy had a significantly improved response rate and longer progression-free survival than patients treated with topotecan (Hycamtin), according to research presented at the 14th World Conference on Lung Cancer in Amsterdam, hosted by the International Association for the Study of Lung Cancer (IASLC).
"Amrubicin showed significant improvements in tumor shrinkage, symptom control and progression-free survival over topotecan without improving overall survival, the primary endpoint of the trial," said principal investigator Dr. Joachim von Pawel, of the Asklepios Hospital Munich-Gauting in Germany. "However, for patients with the most difficult-to-treat small cell lung cancer, amrubicin offered an improvement in overall survival compared with topotecan."
Second-line treatment is given to patients after the initial, or first-line, treatment has failed.
In the study, 637 patients were randomized to amrubicin or to topotecan. Patients on amrubicin reported better symptom control and quality of life (Lung Cancer Symptom Scale 0.2 vs 5.6 and LCSS-SB -0.1 vs 5.2 for amrubicin and topotecan, respectively). They also reported fewer adverse events, including neutropenia (41% vs 53% for the topotecan arm), thrombocytopenia (21% vs 54%), anemia (16% vs 30%), infections (16% vs 10%), febrile neutropenia (10% vs 4%), all P END
ELSE PRESS RELEASES FROM THIS DATE:
2011-07-10
In the largest reported series yet to compare transcervical extended mediastinal lymphadenectomy (TEMLA) with endoscopic and surgical primary staging and restaging of non-small cell lung cancer (NSCLC), TEMLA showed a significantly higher diagnostic yield, according to research presented at the 14th World Conference on Lung Cancer in Amsterdam, hosted by the International Association for the Study of Lung Cancer (IASLC).
Diagnostic yield refers to the likelihood that a procedure will provide the necessary information to establish a diagnosis.
In the study, 617 patients ...
2011-07-10
Patients who underwent endoscopic testing prior to surgery for lung cancer had significantly better quality of life at the end of the staging process, with no significant difference in costs between the two strategies, according to data presented at the 14th World Conference on Lung Cancer in Amsterdam, hosted by the International Association for the Study of Lung Cancer (IASLC).
"Given that assessment of lymph glands using the endoscopic approach was more effective, better tolerated by patients and no more expensive than the surgical approaches, we recommend that investigation ...
2011-07-10
Cancer patients with blood clots -- which occur in one of every 200 cancer patients and are the second most common cause of death among cancer patients -- gain no benefit from the insertion of an inferior vena cava filter (IVCF) to the anticoagulant medication fondaparinux (Arixtra), according to research presented today at the 14th World Conference on Lung Cancer, hosted by the International Association for the Study of Lung Cancer.
"This is the first prospective study to evaluate the treatment of venous thromboembolism (VTE) or blood clots in cancer patients and is ...
2011-07-10
SAN DIEGO, CA – Creating a baseline for each youth athlete is a critical part of accurate future concussion assessment, according to researchers presenting their study at the American Orthopaedic Society for Sports Medicine's Annual Meeting in San Diego. Differences in how females and males scored on a standardized concussion assessment tool were also investigated.
"Our research analyzed whether the new Sport Concussion Assessment Tool-2 (SCAT2) has any variability in data for youth athletes and whether gender makes a difference on the scores," said presenting researcher, ...
2011-07-10
SAN DIEGO, CA – Gender may be associated with an increased risk of cartilage lesions in anterior cruciate ligament (ACL) injured knees, according to research being presented at the American Orthopaedic Society for Sports Medicine's Annual Meeting in San Diego.
"Having articular cartilage lesions (a hole or rough spot in the cartilage of the knee) is considered a predictor of future osteoarthritis-a debilitating joint condition," said lead author Jan Harald Roetterud, MD, from Akershus University Hospital, Lørenskog, Norway. "Our research is exciting because it highlights ...
2011-07-10
SAN DIEGO, CA – A smaller sized hamstring graft in an anterior cruciate ligament (ACL) reconstruction patient less than 20 years old may increase revision rates, according to research presented at the American Orthopaedic Society for Sports Medicine's Annual Meeting in San Diego today.
"Hamstring grafts are commonly used in ACL reconstruction surgeries and vary in size, with the average being 8mm in diameter. Our research illustrated that when a patient was younger than 20 years old and had a graft of less than 8mm, they were more likely to have a future revision surgery," ...
2011-07-10
SAN DIEGO, CA – A history of cancer was a significant risk factor for developing blood clotting issues following knee arthroscopy, according to a study being presented at the American Orthopaedic Society for Sports Medicine's Annual Meeting in San Diego. Researchers from the Mayo Clinic in Rochester, Minnesota analyzed the records of more than 12,000 patients who had undergone the common knee procedure.
"A history of malignancy has not been widely recognized as a significant risk factor for developing a VTE (venous thromboembolytic event) following knee arthroscopy," ...
2011-07-10
An international team of scientists has discovered that the female ancestor of all living polar bears was a brown bear that lived in the vicinity of present-day Britain and Ireland just prior to the peak of the last ice age -- 20,000 to 50,000 years ago. Beth Shapiro, the Shaffer Associate Professor of Biology at Penn State University and one of the team's leaders, explained that climate changes affecting the North Atlantic ice sheet probably gave rise to periodic overlaps in bear habitats. These overlaps then led to hybridization, or interbreeding -- an event that caused ...
2011-07-10
Foxp2, a gene involved in speech and language, helps regulate the wiring of neurons in the brain, according to a study which will be published on July 7th in the open-access journal PLoS Genetics. The researchers identified this functional link by first identifying the major targets of Foxp2 in developing brain tissue and then analysing the function of relevant neurons.
Foxp2 codes for a regulatory protein that provides a window into unusual aspects of brain function. In 2001, scientists discovered that mutations of the human gene cause a rare form of speech and language ...
2011-07-10
Researchers have uncovered a new target that could stop the growth of glioblastoma, a deadly form of brain cancer. In the July 8th issue of the journal Cell, a Cell Press publication, a new study identifies an enzyme found in glioma stem cells that allows them to grow and seed tumors. Importantly, normal stem cells, including those in the brain, don't appear to share that same dependency.
"When thinking about therapeutics [targeting cancer stem cells], you have to be careful that you aren't interfering with normal stem cells," said Christine Eyler of the Cleveland Clinic. ...
LAST 30 PRESS RELEASES:
[Press-News.org] Amrubicin improved response rate and progression-free survival vs. topotecan in Phase III trial
